MedElaj
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
MedElaj - overview
Established
2023
Location
Faridabad, Haryana, India
Primary Industry
Software
About
MedElaj, based in India, specializes in AI-driven health diagnostics. The company offers innovative wellness solutions that provide rapid health assessments, enhancing personal healthcare through advanced technology. MedElaj was founded in 2023 and operates out of Haryana, India, focusing on AI-enhanced health diagnostics. The company has completed one deal, raising USD 100,000 in an Angel funding round on June 1, 2026, which represents the total amount raised.
The founder's history and previous ventures are not specified. MedElaj specializes in advanced AI-driven health diagnostics and wellness solutions, with a core focus on instant health assessments through innovative technology. Their flagship offering utilizes AI face scanning capabilities to evaluate eight vital signs within 60 seconds, providing users with immediate insights into their health status. This technology is designed to enhance personal wellness by allowing individuals to monitor their health proactively and efficiently.
The company serves a diverse clientele, including healthcare providers, wellness centers, and direct consumers seeking accessible health monitoring solutions. MedElaj's products are marketed primarily in regions such as Southeast Asia, the Middle East, and Europe, positioning itself within the health tech space with a commitment to advancing patient care and wellness through scientifically-backed AI. MedElaj operates on a revenue model that includes direct-to-consumer sales and partnerships with healthcare organizations and wellness providers. The company generates income through subscription plans that offer ongoing access to its diagnostic services and insights, catering to both individual users and institutional clients.
Specific transaction structures involve the sale of individual scanning services as well as potential bundled offerings that include multiple health assessments over time. Flagship products such as the AI face scan are expected to form the backbone of the company's revenue, appealing to a growing market of health-conscious consumers and institutions. Pricing plans are structured to accommodate various consumer needs, allowing for scalable access to advanced health monitoring technologies across their target markets. In June 2026, MedElaj raised USD 100,000 in venture funding from individual investors.
The company plans to utilize this funding to support product development, upgrade cloud infrastructure, integrate medical sensors, and manufacture diagnostic kiosks. MedElaj is also looking to expand its geographic footprint into new markets, although specific regions and timelines for these expansions have not been detailed. The funding will facilitate these initiatives as the company continues to develop innovative health solutions.
Primary Industry
Software
Sub Industries
Medical Software
Website
www.medielaj.com/
Verticals
Cloud Computing, Mobile Apps
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.